BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19491223)

  • 1. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs.
    Noh JY; Yasuda S; Sato S; Matsumoto M; Kunii Y; Noguchi Y; Mukasa K; Ito K; Ito K; Sugiyama O; Kobayashi H; Nihojima S; Okazaki M; Yokoyama S
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2806-11. PubMed ID: 19491223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
    Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
    Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY; Asari T; Hamada N; Makino F; Ishikawa N; Abe Y; Ito K; Ito K
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Shuai ZW; Lv YF; Zhang MM; Hu ZY
    Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antineutrophil cytoplasmic antibodies during treatment with benzylthiouracil.
    Sghiri R; Ouertani M; Ben Hsine H; Slim I; Chaieb L; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):410-4. PubMed ID: 19201108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y; Ye H; Yu F; Guo XH; Zhao MH
    Clin Immunol; 2005 Oct; 117(1):87-93. PubMed ID: 16019262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of MPO-ANCA positive vasculitis associated with multiple pulmonary nodules following propylthiouracil treatment].
    Shimizudani N; Senba S; Odaka T; Utsumi K; Nemoto K; Hatao H; Ito M; Adachi H; Kishi K; Oh-ishi S; Nakamura H; Matsuoka T
    Nihon Kokyuki Gakkai Zasshi; 2009 Feb; 47(2):98-103. PubMed ID: 19260531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
    Ye H; Gao Y; Guo XH; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.
    Choi HK; Merkel PA; Walker AM; Niles JL
    Arthritis Rheum; 2000 Feb; 43(2):405-13. PubMed ID: 10693882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
    Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY
    Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effect and clinical findings in patients with MPO-ANCA associated vasculitis syndrome].
    Yoshida A; Takeda A; Fukuda M; Toda S; Morozumi K
    Ryumachi; 2000 Feb; 40(1):1-8. PubMed ID: 10783659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis.
    Zhang AH; Chen M; Gao Y; Zhao MH; Wang HY
    Clin Immunol; 2007 Feb; 122(2):187-93. PubMed ID: 17070108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.